Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum to "PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study" [Biomed. Pharmacother. 159 (2023) 114220].
Salgüero S, Brochado-Kith Ó, Verdices AV, Berenguer J, González-García J, Martínez I, Díez C, Hontañón V, Pérez-Latorre L, Fernández-Rodríguez A, Jiménez-Sousa MÁ, Resino S. Salgüero S, et al. Biomed Pharmacother. 2023 Jul;163:114803. doi: 10.1016/j.biopha.2023.114803. Epub 2023 Apr 27. Biomed Pharmacother. 2023. PMID: 37120412 Free article. No abstract available.
Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].
Berenguer J, Laguna F, López-Aldeguer J, Moreno S, Arribas JR, Arrizabalaga J, Baraia J, Casado JL, Cosín J, Polo R, González-García J, Iribarren JA, Kindelán JM, López-Bernaldo de Quirós JC, López-Vélez R, Lorenzo JF, Lozano F, Mallolas J, Miró JM, Pulido F, Ribera E. Berenguer J, et al. Enferm Infecc Microbiol Clin. 2004 Mar;22(3):160-76. doi: 10.1016/s0213-005x(04)73057-8. Enferm Infecc Microbiol Clin. 2004. PMID: 14987537 Review. English, Spanish.
Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Berenguer J, Alvarez-Pellicer J, Martín PM, López-Aldeguer J, Von-Wichmann MA, Quereda C, Mallolas J, Sanz J, Tural C, Bellón JM, González-García J; GESIDA3603/5607 Study Group. Berenguer J, et al. Hepatology. 2009 Aug;50(2):407-13. doi: 10.1002/hep.23020. Hepatology. 2009. PMID: 19575364
Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus.
Berenguer J, von Wichmann MA, Quereda C, Miralles P, Mallolas J, López-Aldeguer J, Alvarez-Pellicer J, De Miguel J, Crespo M, Guardiola JM, Tellez MJ, Galindo MJ, Arponen S, Barquilla E, Bellón JM, González-García J; GESIDA 36/03 and 50/06 Study Groups. Berenguer J, et al. J Antimicrob Chemother. 2011 Dec;66(12):2843-9. doi: 10.1093/jac/dkr362. Epub 2011 Sep 29. J Antimicrob Chemother. 2011. PMID: 21965432
Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis.
Montes Ramirez ML, Pascual-Pareja JF, Sánchez-Conde M, Bernardino De la Serna JI, Zamora Vargas FX, Miralles P, Castro JM, Ramírez M, Gutierrez I, Gonzalez-García J, Berenguer J, Arribas López JR. Montes Ramirez ML, et al. AIDS. 2012 Sep 10;26(14):1807-12. doi: 10.1097/QAD.0b013e3283573267. AIDS. 2012. PMID: 22781218
Mitochondrial haplogroups are associated with clinical pattern of AIDS progression in HIV-infected patients.
Guzmán-Fulgencio M, Jiménez JL, García-Álvarez M, Bellón JM, Fernández-Rodriguez A, Campos Y, Rodríguez C, González-Garcia J, Riera M, Viciana P, Muñoz-Fernández MÁ, Resino S. Guzmán-Fulgencio M, et al. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):178-83. doi: 10.1097/QAI.0b013e3182893f74. J Acquir Immune Defic Syndr. 2013. PMID: 23666137
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis.
Berenguer J, Zamora FX, Carrero A, Von Wichmann MA, Crespo M, López-Aldeguer J, Aldámiz-Echevarría T, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Esteban H, Bellón JM, González-García J; GESIDA HIVHCV Cohort Study Group. Berenguer J, et al. J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):280-7. doi: 10.1097/QAI.0000000000000156. J Acquir Immune Defic Syndr. 2014. PMID: 25157646
Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Blasco AJ, Llibre JM, Berenguer J, González-García J, Knobel H, Lozano F, Podzamczer D, Pulido F, Rivero A, Tuset M, Lázaro P, Gatell JM; GESIDA ART Cost-efficacy Study Group. Blasco AJ, et al. Enferm Infecc Microbiol Clin. 2015 Mar;33(3):156-65. doi: 10.1016/j.eimc.2014.05.016. Epub 2014 Aug 28. Enferm Infecc Microbiol Clin. 2015. PMID: 25175171
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
Berenguer J, Zamora FX, Aldámiz-Echevarría T, Von Wichmann MA, Crespo M, López-Aldeguer J, Carrero A, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Barros C, Ortega E, Pulido F, Rubio R, Mallolas J, Tural C, Jusdado JJ, Pérez G, Díez C, Álvarez-Pellicer J, Esteban H, Bellón JM, González-García J; Grupo de Estudio del SIDA (GESIDA) HIV/HCV Cohort Study Group. Berenguer J, et al. Clin Infect Dis. 2015 Mar 15;60(6):950-8. doi: 10.1093/cid/ciu939. Epub 2014 Nov 24. Clin Infect Dis. 2015. PMID: 25422386
598 results